Neurovalens, a global leader in non-invasive neuro-technology, has today announced the appointment of an experienced MedTech professional to drive growth in the US market. Kate Willis has been appointed as the Vice President of Commercialization, where she will oversee the sales of Neurovalens’ prescribed medical devices in the US and work towards securing reimbursement approvals from private healthcare insurance providers. Neurovalens, a pioneering health-tech company based in Belfast, Northern Ireland, specializes in leveraging the power of neuroscience and advanced technology to address a variety of global health challenges. Over the past year, Neurovalens has achieved significant milestones by obtaining medical device clearance from the US Food & Drug Administration (FDA) for two innovative products: the Modius Stress device for treating … Continue reading Neurovalens appoints Kate Willis as Vice President of Commercialization